April 28, 2022
Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
Code number: | 4519 (Prime Market of Tokyo Stock Exchange) |
Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
President & CEO: | Osamu Okuda |
Inquiries to: | Toshiya Sasai |
Head of Corporate Communications Dept. | |
Tel: +81-(0)3-3273-0554 |
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 28, 2022--Chugai Pharmaceutical Co., Ltd. announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 29, 2022. The result of treasury shares is as follows.
1. | Overview of Disposal |
(1) Disposal date | April 28, 2022 |
(2) Class and number of disposed shares | 91,300 shares of Common stock of the Company |
(3) Disposal price | ¥4,158 per share |
(4) Total value of disposed shares | ¥379,625,400 |
(5) Allottees and number thereof; | Directors 3 | 46,600 shares |
number of disposed shares | Vice presidents 12 | 17,800 shares |
Employees 110 | 26,900 shares |
###
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 02:43:07 UTC.